Cercar
02/01/2024
Durability and long-term outcomes of biologic therapies in psoriasis
Rusinol, L, Carmona-Rocha E., Puig L.. Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology. 2024; 20(1)DOI:10.1080/1744666X.2023.2250918. PMID:37610817. IF:3.700(Q2/5D).
01/01/2024
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients
Manzanares N., Vilarrasa E., López A., Alonso M.L., Velasco M., Riera J., del Alcázar E., Carrascosa J.M., Azón A., Rivera R., Santos S., Salgado-Boquete L., Roncero M., Dorado M., Yelamos O., Delgado C., Gallardo F., Ferran M.. No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(1)DOI:10.1111/jdv.19406. PMID:37561934. IF:8.000(Q1/1D).
01/01/2024
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis
Rusiñol, L, Puig, L. Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(2)DOI:10.3390/ijms25021042. PMID:38256115. IF:4.900(Q1/3D).
01/01/2024
Exposome and basal cell carcinoma: a multicenter case–control study
Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De-la-Fuente-Meira S., Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Bañuls J., Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. Exposome and basal cell carcinoma: a multicenter case–control study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(7)DOI:10.1111/ijd.17026. PMID:38282244. IF:3.200(Q1/3D).
20/12/2023
Disseminated Monomorphic Pink Papules
Rusiñol, L, Mozos, A, Yélamos, O. Disseminated Monomorphic Pink Papules. JAMA Dermatology. 2023; 159(12)DOI:10.1001/jamadermatol.2023.3586. PMID:37938840. IF:11.500(Q1/1D).
18/12/2023
Price variability of TNF-a inhibitor biosimilars among European countries
Geat, D, Gisondi, P, Maurelli, M, Puig, L, Paul, C, Thaci, D, Iversen, L, Bellinato, F, Girolomoni, G. Price variability of TNF-a inhibitor biosimilars among European countries. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19756. PMID:38108512. IF:8.500(Q1/1D).
13/12/2023
Sodium metabisulfite a current low relevant allergen in Spain
Sanz-Sánchez, T, Giménez-Arnau, AM, Mercader-García, P, Perez, RG, Zaragoza-Ninet, V, Miquel-Miquel, J, Silvestre-Salvador, JF, Córdoba-Guijarro, S, Carrascosa-Carrillo, JM, Gática-Ortega, ME, Ruíz-Gonzalez, I, Tous-Romero, F, Ortiz-de Frutos, FJ, Serra-Baldrich, E, Pastor-Nieto, A, Rodríguez-Serna, M, Sánchez-Pérez, J, Gilo, AS, Melé-Ninot, G, Guillén, PSP, García-Doval, I, Borrego, L. Sodium metabisulfite a current low relevant allergen in Spain. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19702. PMID:38088580. IF:8.500(Q1/1D).
10/12/2023
An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis
Eyerich, K, Krueger, J, Stahle, M, Schakel, K, Conrad, C, Armstrong, A, Gniadecki, R, Puig, L, Scoble, T, Williams, N. An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19652. PMID:38071690. IF:8.500(Q1/1D).